Phase 1 Three Part SAD, MAD & Cross-Over Study of ZP-059 in Healthy and Asthmatic Subjects

NCT04229303 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

58

Enrollment

INDUSTRY

Sponsor class

Conditions

Allergic Bronchopulmonary Aspergillosis

Interventions

DRUG: Voriconazole inhaled
DRUG: oral voriconazole

Sponsor

Zambon SpA